These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
172 related articles for article (PubMed ID: 32154509)
21. Utility of Films to Anticipate Effect of Drug Load and Polymer on Dissolution Performance from Tablets of Amorphous Itraconazole Spray-Dried Dispersions. Honick M; Sarpal K; Alayoubi A; Zidan A; Hoag SW; Hollenbeck RG; Munson EJ; Polli JE AAPS PharmSciTech; 2019 Nov; 20(8):331. PubMed ID: 31677012 [TBL] [Abstract][Full Text] [Related]
22. Spray-Dried Paracetamol/Polyvinylpyrrolidone Amorphous Solid Dispersions: Part I-Stability of Powders and Tablets. Ritters L; Tian Y; Reichl S Pharmaceutics; 2021 Nov; 13(11):. PubMed ID: 34834353 [TBL] [Abstract][Full Text] [Related]
23. Physical Stability and Dissolution of Lumefantrine Amorphous Solid Dispersions Produced by Spray Anti-Solvent Precipitation. Bhujbal SV; Pathak V; Zemlyanov DY; Taylor LS; Zhou QT J Pharm Sci; 2021 Jun; 110(6):2423-2431. PubMed ID: 33387599 [TBL] [Abstract][Full Text] [Related]
24. Relevance of Liquid-Liquid Phase Separation of Supersaturated Solution in Oral Absorption of Albendazole from Amorphous Solid Dispersions. Suzuki K; Kawakami K; Fukiage M; Oikawa M; Nishida Y; Matsuda M; Fujita T Pharmaceutics; 2021 Feb; 13(2):. PubMed ID: 33562770 [TBL] [Abstract][Full Text] [Related]
25. Thermodynamic and kinetic evaluation of the impact of polymer excipients on storage stability of amorphous itraconazole. Zhang S; Lee TWY; Chow AHL Int J Pharm; 2019 Jan; 555():394-403. PubMed ID: 30513399 [TBL] [Abstract][Full Text] [Related]
26. Pharmaceutical amorphous solid dispersion: A review of manufacturing strategies. Bhujbal SV; Mitra B; Jain U; Gong Y; Agrawal A; Karki S; Taylor LS; Kumar S; Tony Zhou Q Acta Pharm Sin B; 2021 Aug; 11(8):2505-2536. PubMed ID: 34522596 [TBL] [Abstract][Full Text] [Related]
27. Amorphous Solid Dispersions Layered onto Pellets-An Alternative to Spray Drying? Neuwirth M; Kappes SK; Hartig MU; Wagner KG Pharmaceutics; 2023 Feb; 15(3):. PubMed ID: 36986625 [TBL] [Abstract][Full Text] [Related]
28. Utility of hydroxypropylmethylcellulose acetate succinate (HPMCAS) for initiation and maintenance of drug supersaturation in the GI milieu. Curatolo W; Nightingale JA; Herbig SM Pharm Res; 2009 Jun; 26(6):1419-31. PubMed ID: 19277850 [TBL] [Abstract][Full Text] [Related]
30. Physical stability of API/polymer-blend amorphous solid dispersions. Lehmkemper K; Kyeremateng SO; Bartels M; Degenhardt M; Sadowski G Eur J Pharm Biopharm; 2018 Mar; 124():147-157. PubMed ID: 29269154 [TBL] [Abstract][Full Text] [Related]
31. Fed- and Fasted-State Performance of Pretomanid Amorphous Solid Dispersions Formulated with an Enteric Polymer. Nguyen HT; Van Duong T; Jaw-Tsai S; Bruning-Barry R; Pande P; Taneja R; Taylor LS Mol Pharm; 2023 Jun; 20(6):3170-3186. PubMed ID: 37220082 [TBL] [Abstract][Full Text] [Related]
32. Correlationship of Drug-Polymer Miscibility, Molecular Relaxation and Phase Behavior of Dipyridamole Amorphous Solid Dispersions. Sharma J; Singh B; Agrawal AK; Bansal AK J Pharm Sci; 2021 Apr; 110(4):1470-1479. PubMed ID: 33333143 [TBL] [Abstract][Full Text] [Related]
33. Jermain SV; Lowinger MB; Ellenberger DJ; Miller DA; Su Y; Williams RO Mol Pharm; 2020 Aug; 17(8):2789-2808. PubMed ID: 32520562 [TBL] [Abstract][Full Text] [Related]
34. A comparative study of the effect of spray drying and hot-melt extrusion on the properties of amorphous solid dispersions containing felodipine. Mahmah O; Tabbakh R; Kelly A; Paradkar A J Pharm Pharmacol; 2014 Feb; 66(2):275-84. PubMed ID: 24433426 [TBL] [Abstract][Full Text] [Related]
35. Evaluation of griseofulvin binary and ternary solid dispersions with HPMCAS. Al-Obaidi H; Buckton G AAPS PharmSciTech; 2009; 10(4):1172-7. PubMed ID: 19842041 [TBL] [Abstract][Full Text] [Related]
36. Synergistic and antagonistic effects of various amphiphilic polymer combinations in enhancing griseofulvin release from ternary amorphous solid dispersions. Rahman M; Coelho A; Tarabokija J; Ahmad S; Radgman K; Bilgili E Eur J Pharm Sci; 2020 Jul; 150():105354. PubMed ID: 32380151 [TBL] [Abstract][Full Text] [Related]
37. Enhanced kinetic solubility profiles of indomethacin amorphous solid dispersions in poly(2-hydroxyethyl methacrylate) hydrogels. Sun DD; Ju TC; Lee PI Eur J Pharm Biopharm; 2012 May; 81(1):149-58. PubMed ID: 22233548 [TBL] [Abstract][Full Text] [Related]
38. Preparation and Characterization of Spray-Dried Hybrid Nanocrystal-Amorphous Solid Dispersions (HyNASDs) for Supersaturation Enhancement of a Slowly Crystallizing Drug. Rahman M; Radgman K; Tarabokija J; Ahmad S; Bilgili E Nanomaterials (Basel); 2023 Aug; 13(17):. PubMed ID: 37686927 [TBL] [Abstract][Full Text] [Related]
39. Physical stability of hydroxypropyl methylcellulose-based amorphous solid dispersions: Experimental and computational study. Iemtsev A; Hassouna F; Mathers A; Klajmon M; Dendisová M; Malinová L; Školáková T; Fulem M Int J Pharm; 2020 Nov; 589():119845. PubMed ID: 32931845 [TBL] [Abstract][Full Text] [Related]
40. Spray-Dried Amorphous Solid Dispersions of Atorvastatin Calcium for Improved Supersaturation and Oral Bioavailability. Kwon J; Giri BR; Song ES; Bae J; Lee J; Kim DW Pharmaceutics; 2019 Sep; 11(9):. PubMed ID: 31500147 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]